2012 Brazilian Society Of Rheumatology Consensus On The Management Of Comorbidities In Patients With Rheumatoid Arthritis

dc.creatorPereira I.A.
dc.creatorMota L.M.H.
dc.creatorCruz B.A.
dc.creatorBrenol C.V.
dc.creatorFronza L.S.R.
dc.creatorBertolo M.B.
dc.creatorFreitas M.V.C.
dc.creatorSilva N.A.
dc.creatorLouzada-Junior P.
dc.creatorGiorgi R.D.N.
dc.creatorLima R.A.C.
dc.creatorPinheiro G.R.C.
dc.date2012
dc.date2015-06-26T20:29:48Z
dc.date2015-11-26T14:26:24Z
dc.date2015-06-26T20:29:48Z
dc.date2015-11-26T14:26:24Z
dc.date.accessioned2018-03-28T21:29:27Z
dc.date.available2018-03-28T21:29:27Z
dc.identifier
dc.identifierRevista Brasileira De Reumatologia. , v. 52, n. 4, p. 483 - 495, 2012.
dc.identifier4825004
dc.identifier10.1590/S0482-50042012000400002
dc.identifierhttp://www.scopus.com/inward/record.url?eid=2-s2.0-84866563479&partnerID=40&md5=a99b25bdc45ce8e1425bc58e284dab67
dc.identifierhttp://www.repositorio.unicamp.br/handle/REPOSIP/97179
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/97179
dc.identifier2-s2.0-84866563479
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1246075
dc.descriptionObjective: To elaborate recommendations of the Rheumatoid Arthritis Committee of the Brazilian Society of Rheumatology (SBR) to manage comorbidities in rheumatoid arthritis (RA). Methods: To review the literature and the opinions of the SBR RA Committee experts. Results and conclusions: Recommendations: 1) Early diagnosis and proper treatment of comorbidities are recommended; 2) The specific treatment of RA should be adapted to the presence of comorbidities; 3) Angiotensin-converting-enzyme inhibitors or angiotensin II receptor blockers are preferred to treat systemic arterial hypertension; 4) In patients diagnosed with rheumatoid arthritis and diabetes mellitus, the continuous use of a high cumulative dose of corticoids should be avoided; 5) Statins should be used to maintain LDL cholesterol levels under 100 mg/dL and the atherosclerotic index lower than 3.5 in patients with RA who have other comorbidities; 6) Metabolic syndrome should be treated; 7) Performing non-invasive tests to investigate subclinical atherosclerosis is recommended; 8) Greater surveillance for the early diagnosis of occult malignancy is recommended; 9) Preventive measures of venous thrombosis are suggested; 10) Bone densitometry is recommended in RA patients over the age of 50 years and in younger patients on corticoid therapy at a dose greater than 7.5 mg for over three months; 11) Patients with RA and osteoporosis should be instructed to avoid falls, to increase their dietary calcium intake and sun exposure, and to exercise; 12) Calcium and vitamin D supplementation is suggested. Bisphosphonates are suggested for patients with T score < -2.5 on bone densitometry; 13) A multidisciplinary team, with the active participation of a rheumatologist, is recommended to treat comorbidities. © 2012 Elsevier Editora Ltda.
dc.description52
dc.description4
dc.description483
dc.description495
dc.descriptionMcInnes, I.B., O'Dell, J.R., State-of-the-art: rheumatoid arthritis (2010) Ann Rheum Dis, 69 (11), pp. 1898-1906. , [Erratum in: Ann Rheum Dis 2011
dc.description70(2):399]
dc.descriptionMcInnes, I.B., Schett, G., The pathogenesis of rheumatoid arthritis (2011) N Engl J Med, 365 (23), pp. 2205-2219
dc.descriptionAllaart, C.F., Huizinga, T.W., Treatment strategies in recent onset rheumatoid arthritis (2011) Curr Opin Rheumatol, 23 (3), pp. 241-244
dc.descriptionSymmons, D.P., Rheumatoid arthritis: assessing disease activity and outcome (2010) Clin Med, 10 (3), pp. 248-251
dc.descriptionGonzalez, A., Maradit Kremers, H., Crowson, C.S., Nicola, P.J., Davis 3rd, J.M., Therneau, T.M., The widening mortality gap between rheumatoid arthritis patients and the general population (2007) Arthritis Rheum, 56 (11), pp. 3583-3587
dc.descriptionHemminki, K., Li, X., Sundquist, J., Sundquist, K., Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions (2009) Arthritis Rheum, 60 (3), pp. 661-668
dc.descriptionMichou, L., Rat, A.C., Lasbleiz, S., Bardin, T., Cornélis, F., Prevalence and distribution of autoimmune diseases in 368 rheumatoid arthritis families (2008) J Rheumatol, 35 (5), pp. 790-796
dc.descriptionMichaud, K., Wolfe, F., Comorbidities in rheumatoid arthritis (2007) Best Pract Res Clin Rheumatol, 21 (5), pp. 885-906
dc.descriptionCrowson, C.S., Myasoedova, E., Davis 3rd, J.M., Matteson, E.L., Roger, V.L., Therneau, T.M., Increased Prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease (2011) J Rheumatol, 38 (1), pp. 29-35
dc.descriptionChung, C.P., Oeser, A., Solus, J.F., Avalos, I., Gebretsadik, T., Shintani, A., Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis (2008) Atherosclerosis, 196 (2), pp. 756-763
dc.descriptionSteiner, G., Urowitz, M.B., Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment (2009) Semin Arthritis Rheum, 38 (5), pp. 372-381
dc.descriptionSolomon, D.H., Love, T.J., Canning, C., Schneeweiss, S., Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis (2010) Ann Rheum Dis, 69 (12), pp. 2114-2117
dc.descriptionvan Halm, V.P., Peters, M.J., Voskuyl, A.E., Boers, M., Lems, W.F., Visser, M., Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation (2009) Ann Rheum Dis, 68 (9), pp. 1395-1400
dc.descriptionPanoulas, V.F., Douglas, K.M., Milionis, H.J., Stavropoulos-Kalinglou, A., Nightingale, P., Kita, M.D., Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis (2007) Rheumatology (Oxford), 46 (9), pp. 1477-1482
dc.descriptionKitas, G.D., Gabriel, S.E., Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives (2011) Ann Rheum Dis, 70 (1), pp. 8-14
dc.descriptionGonzalez, A., Maradit Kremers, H., Crowson, C.S., Ballman, K.V., Roger, V.L., Jacobsen, S.J., Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in nonrheumatoid arthritis patients? (2008) Ann Rheum Dis, 67 (1), pp. 64-69
dc.descriptionPanoulas, V.F., Douglas, K.M., Stavropoulos-Kalinoglou, A., Metsios, G.S., Nightingale, P., Kita, M.D., Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis (2008) Rheumatology (Oxford), 47 (1), pp. 72-75
dc.descriptionAlcorn, N., Saunders, S., Madhok, R., Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing (2009) Drug Saf, 32 (12), pp. 1123-1134
dc.descriptionRobert, N., Wong, G.W., Wright, J.M., Effect of cyclosporine on blood pressure (2010) Cochrane Database Syst Rev, (1), pp. CD007893
dc.descriptionAtzeni, F., Turiel, M., Caporali, R., Cavagna, L., Tomasoni, L., Sitia, S., The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases (2010) Autoimmunity Rev, 9 (12), pp. 835-839
dc.descriptionWhite, W.B., Defining the problem of treating the patient with hypertension and arthritis pain (2009) Am J Med, 122 (5 SUPPL.), pp. S3-S9
dc.descriptionPeters, M.J., Symmons, D.P., McCarey, D., Dijkmans, B.A., Nicola, P., Kvien, T.K., EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis (2010) Ann Rheum Dis, 69 (2), pp. 325-331
dc.descriptionSolomon, D.H., Massarotti, E., Garg, R., Liu, J., Canning, C., Schneeweiss, S., Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis (2011) JAMA, 305 (24), pp. 2525-2531
dc.descriptionTentolouris, N., Arapostathi, C., Voulgari, C., Grammatikou, S., Andrianakos, A., Sfikakis, P.P., The effect of diabetes mellitus on the prevalence of rheumatoid arthritis: a case-control study (2008) Diabet Med, 25 (8), pp. 1010-1011
dc.descriptionHan, C., Robinson Jr., D.W., Hackett, M.V., Paramore, L.C., Fraeman, K.H., Bala, M.V., Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis (2006) J Rheumatol, 33 (11), pp. 2167-2172
dc.descriptionHoes, J.N., van der Goes, M.C., van Raalte, D.H., van der Zijl, N.J., den Uyl, D., Lems, W.F., Glucose tolerance, insulin sensitivity and β-cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids (2011) Ann Rheum Dis, 70 (11), pp. 1887-1894
dc.descriptionWasko, M.C., Kay, J., Hsia, E.C., Rahman, M.U., Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease (2011) Arthritis Care Res (Hoboken), 63 (4), pp. 512-521
dc.descriptionAntohe, J.L., Bili, A., Sartorius, J.A., Lester Kirchner, H., Morris, S.J., Dancea, S., Diabetes risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor- α therapy (2012) Arthritis Care Res (Hoboken), 64 (2), pp. 215-221
dc.descriptionBili, A., Sartorius, J.A., Kirchner, H.L., Morris, S.J., Ledwich, L.J., Antohe, J.L., Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients (2011) J Clin Rheumatol, 17 (3), pp. 115-120
dc.descriptionLiao, K.P., Gunnarsson, M., Källberg, H., Ding, B., Plenge, R.M., Padyukov, L., Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis (2009) Arthritis Rheum, 60 (3), pp. 653-660
dc.descriptionChoy, E., Sattar, N., Interpreting lipid levels in the context of highgrade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions (2009) Ann Rheum Dis, 68 (4), pp. 460-469
dc.descriptionWhite, D., Fayez, S., Doube, A., Atherogenic lipid profiles in rheumatoid arthritis (2006) N Z Med J, 119 (1240), pp. U2125
dc.descriptionNurmohamed, M.T., Atherogenic lipid profiles and its management in patients with rheumatoid arthritis (2007) Vasc Health Risk Manag, 3 (6), pp. 845-852
dc.descriptionMyasoedova, E., Crowson, C.S., Kremers, H.M., Fitz-Gibbon, P.D., Therneau, T.M., Gabriel, S.E., Total cholesterol and LDL levels decrease before rheumatoid arthritis (2010) Ann Rheum Dis, 69 (7), pp. 1310-1314
dc.descriptionGhosh, U.C., Roy, A., Sen, K., Kundu, A.K., Saha, I., Biswas, A., Dyslipidaemia in rheumatoid arthritis in a tertiary care centre in Eastern India - a non-randomised trial (2009) J Indian Med Assoc, 107 (7), pp. 427-430
dc.descriptionGarciaa-Gómez, C., Nolla, J.M., Valverde, J., Gómez-Gerique, J.A., Castro, M.J., Pintó, X., Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis (2009) J Rheumatol, 36 (7), pp. 1365-1370
dc.descriptionSteiner, G., Urowitz, M.B., Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment (2009) Semin Arthritis Rheum, 38 (5), pp. 372-381
dc.descriptionGeorgiadis, A.N., Papavasiliou, E.C., Lourida, E.S., Alamanos, Y., Kostara, C., Tselepis, A.D., Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment - a prospective, controlled study (2006) Arthritis Res Ther, 8 (3), pp. R82
dc.descriptionSvenson, K.L., Lithell, H., Hallgren, R., Vessby, B., Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment (1987) Arch Intern Med, 147 (11), pp. 1917-1920
dc.descriptionRaynauld, J.P., Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? (1997) J Rheumatol, 24 (3), pp. 415-416
dc.descriptionWallace, D.J., Metzger, A.L., Stecher, V.J., Turnbull, B.A., Kern, P.A., Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids on lipids (1990) Am J Med, 89 (3), pp. 322-326
dc.descriptionvan Halm, V.P., Nielen, M.M., Nurmohamed, M.T., van Schaardenburg, D., Reesink, H.W., Voskuyl, A.E., Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis (2007) Ann Rheum Dis, 66 (2), pp. 184-188
dc.descriptionSingh, J.A., Beg, S., Lopez-Olivo, M.A., Tocilizumab for rheumatoid arthritis. Cochrane Database of Systematic Reviews (2011) J Rheumatol, 38 (1), pp. 10-20
dc.descriptionStorage, S.S., Agrawal, H., Furst, D.E., Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis (2010) Korean J Intern Med, 25 (1), pp. 1-17
dc.descriptionPollono, E.N., Lopez-Olivo, M.A., Lopez, J.A., Suarez-Almazor, M.E., A systematic review of the effect of TNF-alpha antagonists on lipid profiles in patients with rheumatoid arthritis (2010) Clin Rheumatol, 29 (9), pp. 947-955
dc.descriptionMcCarey, D.W., McInnes, I.B., Madhok, R., Hampson, R., Scherbakov, O., Ford, I., Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial (2004) Lancet, 363 (9426), pp. 2015-2021
dc.descriptionChatterjee Adhikari, M., Guin, A., Chakraborty, S., Sinhamahapatra, P., Ghosh, A., Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima-media thickness and flow-mediated vasodilatation: an observational study (2012) Semin Arthritis Rheum, 41 (5), pp. 669-675
dc.descriptionGonzález-Juanatey, C., Llorca, J., González-Gay, M.A., Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease (2011) Arthritis Res Ther, 13 (3), pp. R101
dc.descriptionPereira, I.A., Laurindo, I.M., Zimmermann, A.F., Werner Castro, G.R., Mello, F., Borba, E.F., Single measurements of C-reactive protein and disease activity scores are not predictors of carotid atherosclerosis in rheumatoid arthritis patients (2009) Acta Reumatol Port, 34 (1), pp. 58-64
dc.descriptionChung, C.P., Oeser, A., Raggi, P., Gebretsadik, T., Shintani, A.K., Sokka, T., Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors (2005) Arthritis Rheum, 52 (10), pp. 3045-3053
dc.descriptionMaradit-Kremers, H., Crowson, C.S., Nicola, P.J., Ballman, K.V., Roger, V.L., Jacobsen, S.J., Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study (2005) Arthritis Rheum, 52 (2), pp. 402-411
dc.descriptionNicola, P.J., Maradit-Kremers, H., Roger, V.L., Jacobsen, S.J., Crowson, C.S., Ballman, K.V., The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years (2005) Arthritis Rheum, 52 (2), pp. 412-420
dc.descriptionWestlake, S.L., Colebatch, A.N., Baird, J., Kiely, P., Quinn, M., Choy, E., The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review (2010) Rheumatology (Oxford), 49 (2), pp. 295-307
dc.descriptionWestlake, S.L., Colebatch, A.N., Baird, J., Curzen, N., Kiely, P., Quinn, M., Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review (2011) Rheumatology (Oxford), 50 (3), pp. 518-531
dc.descriptionBarnabe, C., Martin, B.J., Ghali, W.A., Systematic review and metaanalysis: anti-tumor necrosis factor a therapy and cardiovascular events in rheumatoid arthritis (2011) Arthritis Care Res (Hoboken), 63 (4), pp. 522-529
dc.descriptionGislason, G.H., Rasmussen, J.N., Abildstrom, S.Z., Schramm, T.K., Hansen, M.L., Fosbøl, E.L., Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure (2009) Arch Intern Med, 169 (2), pp. 141-149
dc.descriptionSolomon, D.H., Glynn, R.J., Rothman, K.J., Schneeweiss, S., Setoguchi, S., Mogun, H., Subgroup analyses to determine cardiovascular risk associated with nonsteroidal anti-inflammatory drugs and coxibs in specific patient groups (2008) Arthritis Rheum, 59 (8), pp. 1097-1104
dc.descriptionSöderlin, M., Petersson, I., Bergman, S., Svensson, B., Smoking at onset of rheumatoid arthritis (RA) and its effect on disease activity and functional status: experiences from BARFOT, a long-term observational study on early RA (2011) Scand J Rheumatol, 40 (4), pp. 249-255. , BARFOT study group
dc.descriptionSaevarsdottir, S., Wedrén, S., Seddighzadeh, M., Bengtsson, C., Wesley, A., Lindblad, S., Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register cohorts (2011) Arthritis Rheum, 63 (1), pp. 26-36
dc.descriptionAlberti, K.G., Zimmet, P., Shaw, J., Metabolic syndrome - a new worldwide definition. A Consensus Statement from the International Diabetes Federation (2006) Diabet Med, 23 (5), pp. 469-480
dc.description(2001) JAMA, 285 (19), pp. 2846-2897. , Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)
dc.descriptionGrundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. [Executive summary] (2005) Circulation, 112 (17), pp. e285-e290
dc.descriptionSantos, M.J., Fonseca, J.E., Metabolic syndrome, inflammation and atherosclerosis - the role of adipokines in health and in systemic inflammatory rheumatic diseases (2009) Acta Reumatol Port, 34 (4), pp. 590-598
dc.descriptionChung, C.P., Oeser, A., Solus, J.F., Avalos, I., Gebretsadik, T., Shintani, A., Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis (2008) Atherosclerosis, 196 (2), pp. 756-763
dc.descriptionSidiropoulos, P.I., Karvounaris, S.A., Boumpas, D.T., Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications (2008) Arthritis Res Ther, 10 (3), p. 207
dc.descriptionPereira, R.M., de Carvalho, J.F., Bonfa, E., Metabolic syndrome in rheumatological diseases (2009) Autoimmun Rev, 8 (5), pp. 415-419
dc.descriptionda Cunha, V., Brenol, C., Brenol, J., Fuchs, S., Arlindo, E., Melo, I., Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity (2012) Scand J Rheumatol, 41 (3), pp. 186-191
dc.descriptionKarvounaris, S.A., Sidiropoulos, P.I., Papadakis, J.A., Spanakis, E.K., Bertsias, G.K., Kritikos, H.D., Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, crosssectional, controlled, study (2007) Ann Rheum Dis, 66 (1), pp. 28-33
dc.descriptionDessein, P.H., Tobias, M., Veller, M.G., Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis (2006) J Rheumatol, 33 (12), pp. 2425-2432
dc.descriptionLa Montagna, G., Cacciapuoti, F., Buono, R., Manzella, D., Mennillo, G.A., Arciello, A., Insulin resistance is an independent risk factor for atherosclerosis in rheumatoid arthritis (2007) Diab Vasc Dis Res, 4 (2), pp. 130-135
dc.descriptionMottillo, S., Filion, K.B., Genest, J., Joseph, L., Pilote, L., Poirier, P., The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis (2010) J Am Coll Cardiol, 56 (14), pp. 1113-1132
dc.descriptionda Cunha, V.R., Brenol, C.V., Brenol, J.C., Xavier, R.M., Rheumatoid arthritis and metabolic syndrome (2011) Rev Bras Reumatol, 51 (3), pp. 260-268
dc.descriptionToms, T.E., Panoulas, V.F., John, H., Douglas, K.M., Kitas, G.D., Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60 - more than just an anti-inflammatory effect? A cross sectional study (2009) Arthritis Res Ther, 11 (4), pp. R110
dc.descriptionBacani, A.K., Gabriel, S.E., Crowson, C.S., Heit, J.A., Matteson, E.L., Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? (2012) Arthritis Rheum, 64 (1), pp. 53-61
dc.descriptionMatta, F., Singala, R., Yaekoub, A.Y., Najjar, R., Stein, P.D., Risk of venous thromboembolism with rheumatoid arthritis (2009) Thromb Haemost, 101 (1), pp. 134-138
dc.descriptionAksu, K., Donmez, A., Keser, G., Inflammation-induced thrombosis: mechanisms, disease associations and management (2012) Curr Pharm Des, 18 (11), pp. 1478-1493
dc.descriptionUndas, A., Gissel, M., Kwasny-Krochin, B., Gluszko, P., Mann, K.G., Brummel-Ziedins, K.E., Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition (2010) Thromb Haemost, 104 (2), pp. 224-230
dc.descriptionBisoendial, R.J., Levi, M., Tak, P.P., Stroes, E.S., The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events (2010) Semin Thromb Hemost, 36 (4), pp. 452-457
dc.descriptionMameli, A., Barcellona, D., Marongiu, F., Rheumatoid arthritis and thrombosis (2009) Clin Exp Rheumatol, 27 (5), pp. 846-855
dc.descriptionLiang, K.P., Liang, K.V., Matteson, E.L., McClelland, R.L., Christianson, T.J., Turesson, C., Incidence of noncardiac vascular diseasein rheumatoid arthritis and relationship to extraarticular disease manifestations (2006) Arthritis Rheum, 54 (2), pp. 642-648
dc.descriptionDavies, R., Galloway, J.B., Watson, K.D., Lunt, M., Symmons, D.P., Hyrich, K.L., Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (2011) Ann Rheum Dis, 70 (10), pp. 1831-1834. , BSRBR Control Centre Consortium, British Society for Rheumatology Biologics Register
dc.descriptionSmitten, A.L., Simon, T.A., Hochberg, M.C., Suissa, S., A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis (2008) Arthritis Res Ther, 10 (2), pp. R45
dc.descriptionZintzaras, E., Voulgarelis, M., Moutsopoulos, H.M., The risk of lymphoma development in autoimmune diseases: a meta-analysis (2005) Arch Intern Med, 165 (20), pp. 2337-2344
dc.descriptionHemminki, K., Li, X., Sundquist, K., Sundquist, J., Cancer risk in hospitalized rheumatoid arthritis patients (2008) Rheumatology (Oxford), 47 (5), pp. 698-701
dc.descriptionKim, Y.J., Shim, J.S., Choi, C.B., Bae, S.C., Mortality and incidence of malignancy in Korean patients with rheumatoid arthritis (2012) J Rheumatol, 39 (2), pp. 226-232
dc.descriptionBongartz, T., Sutton, A.J., Sweeting, M.J., Buchan, I., Matteson, E.L., Montori, V., Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials (2006) JAMA, 295 (19), pp. 2275-2285
dc.descriptionThompson, A.E., Rieder, S.W., Pope, J.E., Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials (2011) Arthritis Rheum, 63 (6), pp. 1479-1485
dc.descriptionAskling, J., The risk of malignancies in RA patients treated with biologics (2010) Z Rheumatol, 69 (9), pp. 774-779
dc.descriptionThomas, E., Symmons, D.P., Brewster, D.H., Black, R.J., Macfarlane, G.J., National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study (2003) J Rheumatol, 30 (5), pp. 958-965
dc.descriptionHemminki, K., Liu, X., Ji, J., Sundquist, J., Sundquist, K., Autoimmune disease and subsequent digestive tract cancer by histology (2012) Ann Oncol, 23 (4), pp. 927-933
dc.descriptionHellgren, K., Smedby, K.E., Feltelius, N., Baecklund, E., Askling, J., Do rheumatoid arthritis and lymphoma share risk factors? A comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis (2010) Arthritis Rheum, 62 (5), pp. 1252-1258
dc.descriptionMiranda-Duarte, A., Kraus-Weisman, A., Granados, J., Vill, A.R., Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases (2011) Rev Invest Clin, 63 (3), pp. 236-243
dc.descriptionStrangfeld, A., Hierse, F., Rau, R., Burmester, G.R., Krummel-Lorenz, B., Demary, W., Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT (2010) Arthritis Res Ther, 12 (1), pp. R5
dc.descriptionLeombruno, J.P., Einarson, T.R., Keystone, E.C., The safety of antitumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events (2009) Ann Rheum Dis, 68 (7), pp. 1136-1145
dc.descriptionBongartz, T., Warren, F.C., Mines, D., Matteson, E.L., Abrams, K.R., Sutton, A.J., Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials (2009) Ann Rheum Dis, 68 (7), pp. 1177-1183
dc.descriptionAskling, J., van Vollenhoven, R.F., Granath, F., Raaschou, P., Fored, C.M., Baecklund, E., Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment? (2009) Arthritis Rheum, 60 (11), pp. 3180-3189
dc.descriptionDixon, W.G., Watson, K.D., Lunt, M., Mercer, L.K., Hyrich, K.L., Symmons, D.P., Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register (2010) Arthritis Care Res (Hoboken), 62 (6), pp. 755-763. , [Erratum in: Arthritis Care Res (Hoboken) 2010
dc.description62(10):1514.]
dc.descriptionWong, A.K., Kerkoutian, S., Said, J., Rashidi, H., Pullarkat, S.T., Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studies (2012) Clin Rheumatol, 31 (4), pp. 631-636
dc.descriptionMariette, X., Matucci-Cerinic, M., Pavelka, K., Taylor, P., van Vollenhoven, R., Heatley, R., Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis (2011) Ann Rheum Dis, 70 (11), pp. 1895-1904
dc.descriptionAskling, J., Baecklund, E., Granath, F., Geborek, P., Fored, M., Backlin, C., Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register (2009) Ann Rheum Dis, 68 (5), pp. 648-653
dc.descriptionSimon, T.A., Smitten, A.L., Franklin, J., Askling, J., Lacaille, D., Wolfe, F., Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment (2009) Ann Rheum Dis, 68 (12), pp. 1819-1826
dc.descriptionSlimani, S., Lukas, C., Combe, B., Morel, J., Rituximab in rheumatoid arthritis and the risk of malignancies: report from a French cohort (2011) Joint Bone Spine, 78 (5), pp. 484-487
dc.descriptionForsblad D'Elia, H., Larsen, A., Waltbrand, E., Kvist, G., Mellström, D., Saxne, T., Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalized osteoporosis (2003) Ann Rheum Dis, 62 (7), pp. 617-623
dc.descriptionvan Staa, T.P., Geusens, P., Bijlsma, J.W., Leufkens, H.G., Cooper, C., Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis (2006) Arthritis Rheum, 54 (10), pp. 3104-3112
dc.descriptionVis, M., Haavardsholm, E.A., Bøyesen, P., Haugeberg, G., Uhlig, T., Hoff, M., High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis (2011) Osteoporos Int, 22 (9), pp. 2413-2419
dc.descriptionEdwards, C.J., Williams, E., The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis (2010) Osteoporos Int, 21 (8), pp. 1287-1293
dc.descriptionDaoussis, D., Andonopoulos, A.P., Liossis, S.N., Wnt pathway and IL-17: novel regulators of joint remodeling in rheumatic diseases. Looking beyond the RANK-RANKL-OPG axis (2010) Semin Arthritis Rheum, 39 (5), pp. 369-383
dc.descriptionYuan, F.L., Li, X., Lu, W.G., Zhao, Y.Q., Li, C.W., Li, J.P., Type 17 T-helper cells might be a promising therapeutic target for osteoporosis (2012) Mol Biol Rep, 39 (1), pp. 771-774
dc.descriptionKanis, J.A., Borgstrom, F., De Laet, C., Johansson, H., Johnell, O., Jonsson, B., Assessment of fracture risk (2005) Osteoporos Int, 16 (6), pp. 581-589
dc.descriptionBroy, S.B., Tanner, S.B., Official Positions for FRAX® clinical regarding rheumatoid arthritis from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX® (2011) J Clin Densitom, 14 (3), pp. 184-189. , FRAX® Position Development Conference Members
dc.descriptionTourinho, T.F., Capp, E., Brenol, J.C., Stein, A., Physical activity prevents bone loss in premenopausal women with rheumatoid arthritis: a cohort study (2008) Rheumatol Int, 28 (10), pp. 1001-1007
dc.descriptionde Jong, Z., Munneke, M., Lems, W.F., Zwinderman, A.H., Kroon, H.M., Pauwels, E.K., Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trial (2004) Arthritis Rheum, 50 (4), pp. 1066-1076
dc.descriptionPapaioannou, A., Morin, S., Cheung, A.M., Atkinson, S., Brown, J.P., Feldman, S., Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary (2010) CMAJ, 182 (17), pp. 1864-1873
dc.descriptionGrossman, J.M., Gordon, R., Ranganath, V.K., Deal, C., Caplan, L., Chen, W., American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis (2010) Arthritis Care Res (Hoboken), 62 (11), pp. 1515-1526
dc.descriptionMota, L.M.H., Cruz, B.A., Brenol, C.V., Pereira, I.A., Fronza, L.S., Bertolo, M.B., 2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis (2011) Rev Bras Reumatol, 51 (3), pp. 199-219
dc.descriptionda Mota, L.M., Cruz, B.A., Brenol, C.V., Pereira, I.A., Rezende-Fronza, L.S., Bertolo, M.B., 2012 Brazilian Society of Rheumatology Consensus for the treatment of rheumatoid arthritis (2012) Rev Bras Reumatol, 52 (2), pp. 152-174
dc.languageen
dc.publisher
dc.relationRevista Brasileira de Reumatologia
dc.rightsfechado
dc.sourceScopus
dc.title2012 Brazilian Society Of Rheumatology Consensus On The Management Of Comorbidities In Patients With Rheumatoid Arthritis
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución